On March 3, 2026, FDA announced it had issued 30 warning letters to telehealth companies marketing compounded GLP‑1 products whose promotion of compounded GLP‑1s, in FDA’s view, implies equivalence to ...

Medical experts are cautioning that while GLP-1 drugs like Ozempic and Wegovy have transformed diabetes and obesity care, misuse and under-recognized risks could harm some patients. Concerns range ...

GLP-1 drugs can cause side effects such as muscle loss, nutrient deficiencies, nausea, diarrhea, or constipation. GLP-1-friendly foods are marketed to reduce side effects and support treatment. “GLP-1 ...

Conagra, Nestlé and Mission Foods explore GLP-1-friendly labeling while most brands stick to indirect health claims.